Gene therapy in flap survival

Microsurgery

Volumn 24, Issue 3, 2004, Pages 168-173

  Waller, William ^a   Lee, Jonathan ^a   Zhang, Feng ^a   Lineaweaver, William C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN;

ADENOVIRUS; DNA TRANSFER; FIBROBLAST; GENE THERAPY; MYOBLAST; PLASMID; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW; SKIN FLAP SURVIVAL; WOUND HEALING;

BIOLOGICAL MARKERS; GENE THERAPY; GRAFT REJECTION; GRAFT SURVIVAL; GROWTH SUBSTANCES; HUMANS; MICROCIRCULATION; MICROSURGERY; PROGNOSIS; RECONSTRUCTIVE SURGICAL PROCEDURES; SURGICAL FLAPS; TREATMENT OUTCOME;

EID: 2642541767     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/micr.20047     Document Type: Review

References (62)

1. Yim K, Lineaweaver W, Briones R, Tonken H, Hanson M, Newlin L, Pearl R, Buncke H. Critical ischemia time of rat serratus anterior and gracilis muscles. In: Carraro U, Salmon S, editors. Basic and applied myology: perspectives for the 90's. Uni Press, Padova, Italy; 1991. p 373.
2. Pang CY. Ischemia-induced reperfusion injury in muscle flaps: pathogenesis and major source of free radicals. J Reconstr Microsurg 1990;6:77-83.
3. Pang CY, Forrest CR, Mounsey R. Pharmacologic intervention in ischemia-induced reperfusion injury in the skeletal muscle. Microsurgery 1993;14:176-82.
4. Kerrigan CL, Stotland MA. Ischemia reperfusion injury: a review. Microsurgery 1993;14:165-175.
5. Taub PJ, Silver L, Weinberg H. Plastic surgical perspectives on vascular endothelial growth factor as gene therapy for angiogenesis. Plast Reconstr Surg 2000;105:1034-1042.
6. Robinson CJ. Growth factors: therapeutic advances in wound healing. Ann Med 1993;25:535-538.
7. Robinson SN, Talmadge JE. Sustained release of growth factors. In Vivo 2002;16:535-540.
8. Steed DL. The role of growth factors in wound healing. Surg Clin North Am 1997;77:575-586.
9. Lu WW, Ip WY, Jing WM, Holmes AD, Chow SP. Biomechanical properties of thin skin flap after basic fibroblast growth factor (bFGF) administration. Br J Plast Surg 2000;53:225-229.
10. Hom DB, Assefa G. Effects of endothelial cell growth factor on vascular compromised skin flaps. Arch Otolaryngol Head Neck Surg 1992;118:624-628.
11. Ishiguro N, Yabe Y, Shimizu T, Iwata H, Miura T. Basic fibroblast growth factor has a beneficial effect on the viability of random skin flaps in rats. Ann Plast Surg 2000;32:356-360.
12. Rashid MA, Akita S, Rassaque MS, Yoshimoto H, Ishihara H, Fujii T, Tanaka K, Taguchi T. Coadministration of basic fibroblast growth factor and sucrose octasulfate (sucralfate) facilitates the rat dorsal flap survival and viability. Plast Reconstr Surg 1999;103:941-948.
13. Hom DB, Baker SR, Graham LM, McClatchey KD. Utilizing angiogenic agents to expedite the neovascularization process: in skin flaps. Laryngoscope 1988;98:521-526.
14. Im MJ, Kim YS, Edwards RJ, Hoopes JE, Fenselau A. The effect of bovine basic fibroblast growth factor on skin flap survival in rats. Ann Plast Surg 1992;28:242-245.
15. Carroll SM, Carroll CM, Stremel DA, Heilman SJ, Steffen JM, Tobin GR, Barker JH. Vascular delay and administration of basic fibroblast growth factor augment latissimus dorsi muscle flap perfusion and function. Plast Reconstr Surg 2000;105:964-971.
16. Carroll CM, Carroll SM, Schuschke DA, Barker JH. Augmentation of skeletal muscle flap survival using platelet-derived growth factor. Plast Reconstr Surg 1998;102:407-415.
17. Hom DB, Simplot TC, Pernell KJ, Manivel HC, Song CW. Vascular and epidermal effects of fibroblast growth factor on irradiated and nonirradiated skin flaps. Ann Otol Rhinol Laryngol 2000;109:667-675.
18. Padubidri A, Browne E Jr. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg 1996;37:604-611.
19. Tucci MG, Scalise A, Lucarini G, Pierangeli M, Pugnaloni A, Bertani C, Orlando F, Aldini NN, Santoli M, Campodonico A, Gavaudan F, Ricotti G, Bertani A, Biagini G. rhVEGF and experimental rat skin flaps: systemic or local administration and morphological characteristics. Int J Artif Organs 2001;24: 743-751.
20. Wei P, Li F. The effect of vascular endothelial growth factor on survival of skin flap in rats. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 1997;11:376-378.
21. Sun T, Fu X, Xu M. Effects of bFGF on succinate dehydrogenase level and oxygen consumption of skin flaps in rats. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 1997;11:264-266.
22. Banbury J, Siemionow M, Porvasnik S, Petras S, Browne E. Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor. Plast Reconstr Surg 2000;106:1541-1546.
23. Kryger Z, Dogan T, Zhang F, Komoorowska-Timek E, Shi DY, Cheng C, Lineaweaver WC, Buncke HJ. Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat. Ann Plast Surg 1999;43:172-178.
24. Pu LL, Ahmed S, Thomson JG, Reid MA, Madsen JA, Restifo RJ. Endothelial cell growth factor enhances musculocutaneous flap survival through the process of neovascularization. Ann Plast Surg 1999;42:306-312.
25. Hom DB, Medhi K, Assefa G, Juhn SK, Johnston TP. Vascular effects of sustained-release fibroblast growth factors. Ann Otol Rhinol Laryngol 1996;105:109-116.
26. Plautz GE, Nabel EG, Fox B, Yang ZY, Jaffe M, Gordon D, Chang A, Nabel GJ. Direct gene transfer for the understanding and treatment of human disease. Ann NY Acad Sci 1994;716:144-153.
27. Ghazizadeh S, Taichman LB. Virus-mediated gene transfer for cutaneous gene therapy. Hum Gene Ther 2000;11:2247-2251.
28. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992;267: 26031-26037.
29. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993;4:1317-1326.
30. Kryger Z, Zhang F, Dogan T, Cheng C, Lineaweaver WC, Buncke HJ. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg 2000;53:234-239.
31. Zhang F, Fischer K, Komorowska-Timek E, Guo M, Cui D, Dorsett-Martin W, Buncke HJ, Lineaweaver WC. Improvement of skin paddle survival by application of vascular endothelial growth factor in a rat TRAM flap model. Ann Plast Surg 2001;46:314-319.
32. Li Q, Ping P, Zhang D. Vascular endothelial growth factor (VEGF) accelerates maturation of prefabricated flap. Zhonghua Zhong Xing Wai Ke Za Zhi 2002;18:69-71.
33. Zhang F, Richards L, Angel MF, Zhang J, Liu H, Dorsett-Martin W, Lineaweaver WC. Accelerating flap maturation by vascular endothelium growth factorin a rat tube flap model. Br J Plast Surg 2002;55:59-63.
34. Kryger Z, Dogan T, Zhang F, Komorowska-Timek E, Shi DY, Cheng C, Lineaweaver WC, Buncke HJ. Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat. Ann Plast Surg 1999;43:172-178.
35. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79:1283-1316.
36. Carter CA, Jolly DG, Worden CE Sr, Hendren DG, Kane CJ. Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol 2003;74:244-255.
37. Davidson JM, Broadley KN. Manipulation of the wound-healing process with basic fibroblast growth factor. Ann NY Acad Sci 1991;638:306-315.
38. Khouri RK, Brown DM, Leal-Khouri SM, Tark KC, Shaw WW. The effect of basic fibroblast growth factor on the neovascularisation process: skin flap survival and staged flap transfers. Br J Plast Surg 1991;44:585-588.
39. Wang X, Yan D, Liu Y. The effect of basic fibroblast growth factor (bFGF) on neovascularization and prefabricated flap survival. Zhonghua Zheng Xing Wai Ke Za Zhi 2002;18:278-279.
40. Hickey MJ, Wilson Y, Hurley JV, Morrison WA. Mode of vascularization of control and basic fibroblast growth factor-stimulated prefabricated skin flaps. Plast Reconstr Surg 1998;101: 1296-1304.
41. O'Kane S, Ferguson MW. Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 1997;29:63-78.
42. Nall AV, Brownlee RE, Colvin CP, Schultz G, Fein D, Cassisi NJ, Nguyen T, Kalra A. Transforming growth factor beta 1 improves wound healing and random flap survival in normal and irradiated rats. Arch Otolaryngol Head Neck Surg 1996;122:171-177.
43. Iwasawa M. Accelerated maturation in prefabricated flaps by transforming growth factor-beta: an experimental study in the rabbit. Ann Plast Surg 1993;31:72-75.
44. Schultz G, Rotatori DS, Clark W. EGF and TGF-alpha in wound healing and repair. J Cell Biochem 1991;45:346-352.
45. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg 2003;90:133-146.
46. Kratz G, Lake M, Gidlund M. Insulin like growth factor-1 and -2 and their role in the re-epithelialisation of wounds: interactions with insulin like growth factor binding protein type 1. Scand J Plast Reconstr Surg Hand Surg 1994;28:107-112.
47. Yuksel E, Weinfeld AB, Cleek R, Jensen J, Wamsley S, Waugh JM, Spira M, Shenaq S. Augmentation of adipofascial flaps using the long-term local delivery of insulin and insulin-like growth factor-1. Plast Reconstr Surg 2000;106:373-382.
48. Walls CM, Gregory CR, Beck LS, Cooke JP, Griffey SM, Kass PH. Effects of growth factors and L-arginine on ischemic skin flaps in rats. Vet Surg 1995;24:484-491.
49. Shima DT, Deutsch U, D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995; 370:203-208.
50. Taub PJ, Marmur JD, Zhang WX, Senderoff D, Nhat PD, Phelps R, Urken ML, Silver L, Weinberg H. Locally administered vascular endothelial growth factor cDNA increases survival of ischemia experimental skin flaps. Plast Reconstr Surg 1998;102: 2033-2039.
51. Taub PJ, Marmur JD, Zhang WX, Senderoff D, Urken ML, Silver L, Weinberg H. Effect of time on the viability of ischemic skin flaps treated with vascular endothelial growth factor (VEGF) cDNA. J Reconstr Microsurg 1998;14:387-390.
52. Neumeister MW, Song YH, Mowlavi A, Suchy H, Mathur A. Effects of liposome-mediated gene transfer of VEGF in ishemic rat gracilis muscle. Microsurgery 2001;21:58-62.
53. Wang F, Shao M, Huang B, Liu Z, Xiong B, Cheng T, Huo M. Subcutaneous injection of plasmid VEGF gene: a method of gene therapy to enhance the viability of random skin flap. Zhonghua Zheng Xing Wai Ke Za Zhi 2002;18:387-390.
54. O'Toole G, MacKenzie D, Kinderman R, Buckley MF, Marucci D, McCarthy N, Poole M. Vascular endothelial growth factor gene therapy in ischaemic rat skin flaps. Br J Plast Surg 2002;55:55-58.
55. Lubiatowski P, Goldman CK, Gurunluoglu R, Carnevale K, Siemionow M. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Reconstr Surg 2002;109:1986-1993.
56. Lubiatowski P, Gurunluoglu R, Goldman CK, Skugor B, Carnevale K, Siemionow M. Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoitein-1 promotes perfusion of muscle flaps. Plast Reconstr Surg 2002;110:149-159.
57. Gurunluoglu R, Ozer K, Skugor B, Lubiatowski P, Carnevale K, Siemionow M. Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene. Ann Plast Surg 2002;49:161-169.
58. Machens HG, Morgan JR, Berthiaume F, Stefanovich P, Reimer R, Berger AC. Genetically modified fibroblasts induce angiogenesis in the rat epigastric island flap. Langenbecks Arch Surg 1998;383:345-350.
59. Machens HG, Morgan JR, Berthiaume F, Stefanovich P, Siemers F, Krapohl B, Berger A, Mailander P. Platelet-derived growth factor-AA-mediated functional angiogenesis in the rat epigastric island flap after genetic modification of fibroblasts is ischemia dependent. Surgery 2002;131:393-400.
60. Rinsch C, Quinodoz P, Pittet B, Alizadeh N, Baetens D, Montandon D, Aebischer P, Pepper MS. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther 2001;8:523-533.
61. Le Doux J, Yarmush M. Engineering gene transfer technologies: retroviral-mediated gene transfer. BMES Bull 1996;20:3-8.
62. Morgan JR, Toompkins RG, Yarmush ML. Advances in recombinant retroviruses for gene delivery. Adv Drug Deliv Rev 1993;12:143-158.